Infection with human T-lymphotropic virus type 1 (HTLV-1) can be associated with
hematologic malignancy, inflammatory syndromes, or infectious complications. Herein, we …

Infection by human T-lymphotropic virus 1 (HTLV-1) is often seen as the cause of chronic
infection or lymphoproliferative disorders, but many clinicians do not recognise its …

As an acquired immunodeficiency, human immunodeficiency virus (HIV) infection is
primarily responsible for opportunistic infections in infected patients. However, opportunistic …

In an article in the current issue of Clinical Infectious Diseases, Glowacka et al identify a
number of important issues relating to human T-cell lymphotropic virus type 1 (HTLV-1) …

Human T-lymphotropic virus 1 (HTLV-1) is an important human pathogen. A fair estimate
indicates that at least 5–10 million people harbor the virus worldwide (Legrand et al., 2022) …

We have read with interest the case report of severe gastrointestinal histoplasmosis in a
patient infected with Human T lymphotropic virus-1 (HTLV-1) by Canelo Aybar and …

Early life exposure to human T cell lymphotropic virus type 1 (HTLV-1) is thought to be an
important risk factor for the development of infective dermatitis in childhood and the …

Human T lymphotropic virus type 1 (HTLV-1) is a retrovirus that causes lifelong T-cell
infection in humans, impacting the host immune response. This virus causes a range of …

It is 30 years since human T-cell leukemia virus type 1 (HTLV-1) was identified as the first
human retrovirus. To assess the implications of the virus for human health it is very important …

Human T-lymphotropic virus type 1 (HTLV-1) is estimated to affect 5 to 10 million people
globally and can cause severe and potentially fatal disease, including adult T-cell …